Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Market Cap	91.11B
Revenue (ttm)	84.85B
Net Income (ttm)	5.61B
Shares Out	44.08M
EPS (ttm)	127.32
PE Ratio	16.24
Forward PE	11.11
Dividend	48.00 (2.32%)
Ex-Dividend Date	Mar 30, 2026

Volume	73,700
Average Volume	81,395
Open	2,058.00
Previous Close	2,067.00
Day's Range	2,035.00 - 2,067.00
52-Week Range	1,878.00 - 2,378.00
Beta	0.01
RSI	42.15
Earnings Date	Feb 5, 2026

About Zeria Pharmaceutical

Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally. The company operates through Ethical Pharmaceuticals Business and Consumer Healthcare Business segments. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and e...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1955
• Employees: 1,746
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4559

Financial Performance

In 2024, Zeria Pharmaceutical's revenue was 87.31 billion, an increase of 15.30% compared to the previous year's 75.73 billion. Earnings were 9.94 billion, an increase of 28.52%.